Literature DB >> 25548060

Triglycerides on the rise: should we swap seats on the seesaw?

Peter Libby1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25548060      PMCID： PMC4471442          DOI： 10.1093/eurheartj/ehu500

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  18 in total

1.  Remnant cholesterol as a causal risk factor for ischemic heart disease.

Authors:  Anette Varbo; Marianne Benn; Anne Tybjærg-Hansen; Anders B Jørgensen; Ruth Frikke-Schmidt; Børge G Nordestgaard
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

2.  Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.

Authors:  Anders Berg Jørgensen; Ruth Frikke-Schmidt; Anders Sode West; Peer Grande; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2012-12-17       Impact factor: 29.983

3.  Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.

Authors:  Meliana Riwanto; Lucia Rohrer; Bernd Roschitzki; Christian Besler; Pavani Mocharla; Maja Mueller; Damir Perisa; Kathrin Heinrich; Lukas Altwegg; Arnold von Eckardstein; Thomas F Lüscher; Ulf Landmesser
Journal:  Circulation       Date:  2013-01-24       Impact factor: 29.690

4.  Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.

Authors:  Anette Varbo; Marianne Benn; Anne Tybjærg-Hansen; Børge G Nordestgaard
Journal:  Circulation       Date:  2013-08-07       Impact factor: 29.690

5.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

Authors:  Jacy Crosby; Gina M Peloso; Paul L Auer; David R Crosslin; Nathan O Stitziel; Leslie A Lange; Yingchang Lu; Zheng-zheng Tang; He Zhang; George Hindy; Nicholas Masca; Kathleen Stirrups; Stavroula Kanoni; Ron Do; Goo Jun; Youna Hu; Hyun Min Kang; Chenyi Xue; Anuj Goel; Martin Farrall; Stefano Duga; Pier Angelica Merlini; Rosanna Asselta; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Wu Yin; Dermot Reilly; Elizabeth Speliotes; Caroline S Fox; Kristian Hveem; Oddgeir L Holmen; Majid Nikpay; Deborah N Farlow; Themistocles L Assimes; Nora Franceschini; Jennifer Robinson; Kari E North; Lisa W Martin; Mark DePristo; Namrata Gupta; Stefan A Escher; Jan-Håkan Jansson; Natalie Van Zuydam; Colin N A Palmer; Nicholas Wareham; Werner Koch; Thomas Meitinger; Annette Peters; Wolfgang Lieb; Raimund Erbel; Inke R Konig; Jochen Kruppa; Franziska Degenhardt; Omri Gottesman; Erwin P Bottinger; Christopher J O'Donnell; Bruce M Psaty; Christie M Ballantyne; Goncalo Abecasis; Jose M Ordovas; Olle Melander; Hugh Watkins; Marju Orho-Melander; Diego Ardissino; Ruth J F Loos; Ruth McPherson; Cristen J Willer; Jeanette Erdmann; Alistair S Hall; Nilesh J Samani; Panos Deloukas; Heribert Schunkert; James G Wilson; Charles Kooperberg; Stephen S Rich; Russell P Tracy; Dan-Yu Lin; David Altshuler; Stacey Gabriel; Deborah A Nickerson; Gail P Jarvik; L Adrienne Cupples; Alex P Reiner; Eric Boerwinkle; Sekar Kathiresan
Journal:  N Engl J Med       Date:  2014-06-18       Impact factor: 91.245

6.  Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

Authors:  Anders Berg Jørgensen; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  N Engl J Med       Date:  2014-06-18       Impact factor: 91.245

7.  Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.

Authors:  Nadeem Sarwar; John Danesh; Gudny Eiriksdottir; Gunnar Sigurdsson; Nick Wareham; Sheila Bingham; S Matthijs Boekholdt; Kay-Tee Khaw; Vilmundur Gudnason
Journal:  Circulation       Date:  2006-12-26       Impact factor: 29.690

Review 8.  The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Authors:  Robert A Hegele; Henry N Ginsberg; M John Chapman; Børge G Nordestgaard; Jan Albert Kuivenhoven; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Olivier S Descamps; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Luis Masana; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Gerald F Watts; Olov Wiklund
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-23       Impact factor: 32.069

9.  Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.

Authors:  Majken K Jensen; Eric B Rimm; Jeremy D Furtado; Frank M Sacks
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

10.  Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion.

Authors:  Chunyu Zheng; Veronica Azcutia; Elena Aikawa; Jose-Luiz Figueiredo; Kevin Croce; Hiroyuki Sonoki; Frank M Sacks; Francis W Luscinskas; Masanori Aikawa
Journal:  Eur Heart J       Date:  2012-08-26       Impact factor: 29.983
View more
  25 in total

Review 1.  Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment.

Authors:  Fabien Picard; Philippe Gabriel Steg
Journal:  Curr Atheroscler Rep       Date:  2021-03-31       Impact factor: 5.113

Review 2.  The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Authors:  Pratik B Sandesara; Salim S Virani; Sergio Fazio; Michael D Shapiro
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 3.  Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.

Authors:  Filippo Crea; Peter Libby
Journal:  Circulation       Date:  2017-09-19       Impact factor: 29.690

4.  Trends in Total Cholesterol, Triglycerides, and Low-Density Lipoprotein in US Adults, 1999-2014.

Authors:  Asher Rosinger; Margaret D Carroll; David Lacher; Cynthia Ogden
Journal:  JAMA Cardiol       Date:  2017-03-01       Impact factor: 14.676

5.  N-(3-Benzoylphenyl)-1H-Indole-2-Carboxamide decreases triglyceride levels by downregulation of Apoc3 gene expression in acute hyperlipidemic rat model.

Authors:  Lama Hamadneh; Luay Al-Essa; Suhair Hikmat; Tariq Al-Qirim; Ghassan Abu Sheikha; Yusuf Al-Hiari; Nisrin Azmy; Ghassan Shattat
Journal:  Mol Cell Biochem       Date:  2017-03-02       Impact factor: 3.396

Review 6.  Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.

Authors:  Adam N Berman; Ron Blankstein
Journal:  Curr Cardiol Rep       Date:  2019-08-05       Impact factor: 2.931

7.  Physical exertion as a trigger of acute coronary syndrome caused by plaque erosion.

Authors:  Ayami Kato; Yoshiyasu Minami; Aritomo Katsura; Yusuke Muramatsu; Toshimitsu Sato; Ryota Kakizaki; Teruyoshi Nemoto; Takuya Hashimoto; Kazuhiro Fujiyoshi; Kentaro Meguro; Takao Shimohama; Junya Ako
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

Review 8.  A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021.

Authors:  Tahreem Iqbal; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2021-07-11       Impact factor: 2.931

Review 9.  The changing landscape of atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2021-04-21       Impact factor: 69.504

10.  Efficacy of Spore Forming Bacilli Supplementation in Patients with Mild to Moderate Elevation of Triglycerides: A 12 week, Randomized, Double-Blind, Placebo Controlled Trial.

Authors:  Andrew W Campbell; Drew Sinatra; Zhiwei Zhang; Stephen T Sinatra
Journal:  Integr Med (Encinitas)       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.